Cover Image
市場調查報告書

美國及西歐的心房纖維顫動市場分析

Analysis of the US and Western European Atrial Fibrillation Market

出版商 Frost & Sullivan 商品編碼 357822
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國及西歐的心房纖維顫動市場分析 Analysis of the US and Western European Atrial Fibrillation Market
出版日期: 2016年05月09日 內容資訊: 英文 104 Pages
簡介

本報告提供美國及西歐的心房纖維顫動市場相關調查,心房纖維顫動的概要與心房纖維顫動市場趨勢,各國趨勢,收益分析,打入市場的主要企業的競爭趨勢等彙整資料。

第1章 摘要整理

第2章 心房纖維顫動概要

  • 患者途徑
  • 心房纖維顫動的管理

第3章 人口統計分析

  • 心律不整的分類
  • 傳統的心房纖維顫動的分類
  • 美國的人口統計趨勢
  • 西歐的人口統計趨勢

第4章 照護的穩定度和公共基礎建設趨勢

  • 照護的穩定度
  • 產業的相關課題
  • 市場趨勢及需求
  • 未來的照護協調的穩定度
  • 要求行動的聲音

第5章 經濟影響

第6章 市場概要

  • 心房纖維顫動治療的5個趨勢
  • 供需的保護蓋
  • 心房纖維顫動的管理
  • 擴大趨勢
  • 恰當的補償
  • 技術主導型

第7章 各國環境

  • 各國趨勢
  • 市場魅力度
  • 目前產業的相關課題
  • 市場趨勢 其他

第8章 收益分析

  • 市場佔有率主要的影響
  • 推動成長要素
  • 市場收益方案分析
  • 各市場區隔
  • 各地區
  • 償付方案

第9章 採購趨勢

第10章 需求分析

第11章 競爭環境

  • 競爭組合:主要供應商和利基供應商
  • 心房纖維顫動治療解決方案供應商:供應商分析
  • 臨床實驗
  • 產業活動:各主要供應商
  • 2020∼2025年的市場方案
  • 2020年的關注企業
  • 2020年的關注技術

第12章 最後

第13章 附錄

第14章 Frost & Sullivan案例

目錄
Product Code: NFA2-01-00-00-00

Beyond Traditional Settings, New Products and Technologies are Re-defining the Market

The evolution of new products and technology has impacted the type of procedures conducted, and clinicians must ensure that they keep pace with these advancements. These factors will play a major role in the adoption of new products, thereby boosting procedure volumes. Ablation continues to strengthen its value proposition in various healthcare systems due to its cost-effectiveness, safety, high accessibility, and clinical value in preliminary diagnosis, while increasingly moving toward more definitive diagnosis. Innovations and acquisitions play an integral part in the rapidly growing AF market and help vendors expand their portfolios and gain a competitive edge.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Study Rationale
  • 4. Study Scope and Key Objectives
  • 5. Scope and Segmentation
  • 6. Measurements
  • 7. AF Market Segmentation

2. ATRIAL FIBRILLATION OVERVIEW

  • 1. Atrial Fibrillation-Patient Pathway
  • 2. Atrial Fibrillation Management-Patient Pathway
  • 3. Atrial Fibrillation Management-Patient Pathway (continued)

3. DEMOGRAPHIC ANALYSIS

  • 1. Arrhythmic Classification
  • 2. Traditional Classification of AF
  • 3. Demographic Trends in the United States
  • 4. Demographic Trends in Western Europe

4. CARE CONTINUUM AND INFRASTRUCTURE TRENDS

  • 1. AF Care Continuum
  • 2. AF Care Continuum (continued)
  • 3. AF Care Continuum (continued)
  • 4. Industry Challenges
  • 5. Market Trends and the Need: Call for Action
  • 6. Market Trends and the Need: Call for Action (continued)
  • 7. Future Care Co-ordination Continuum
  • 8. Care Co-ordination Continuum: Call for Action

5. ECONOMIC IMPACT

  • 1. AF Quick Facts
  • 2. Economic Impact of AF-Cost Analysis

6. MARKET OVERVIEW (MARKET LANDSCAPE)

  • 1. Top 5 Trends in AF Care
  • 2. Demand-Supply Gaps
  • 3. AF Management
  • 4. Expanding Horizons
  • 5. Adequate Coverage
  • 6. Technology-driven

7. COUNTRY LANDSCAPE

  • 1. Country-level Landscape
  • 2. Country-level Landscape (continued)
  • 3. Country-level Landscape (continued)
  • 4. Market Attractiveness
  • 5. Atrial Fibrillation-Current Industry Challenges
  • 6. AF Market Trends
  • 7. US Market-Current Market Overview
  • 8. US AF Care Continuum Mapping-Present and Future
  • 9. Western European Market-Current Market Overview
  • 10. Western European AF Care Continuum Mapping-Present and Future
  • 11. Healthcare Spend
  • 12. Current EP Lab Trends and Impact on AF Treatment
  • 13. EP Practice Trends
  • 14. Achieving Disease-based AF Care

8. REVENUE ANALYSIS

  • 1. Total AF Market Sales and Key Implications
  • 2. Key Growth Drivers for the AF Industry
  • 3. Total AF Market-Revenue Scenario Analysis
  • 4. Total AF Market Percent Revenue by Segment
  • 5. Total AFib Market Revenue Forecast by Region
  • 6. Total AF Market Revenue Forecast by Region (continued)
  • 7. Total AFib Market Percent Revenue Forecast by Region and Segment
  • 8. Reimbursement Scenario

9. PROCUREMENT LANDSCAPE

  • 1. Procurement Landscape
  • 2. Procurement Trends-Atrial Fibrillation Device Systems
  • 3. Procurement Trends-Atrial Fibrillation Device Systems (continued)

10. DEMAND ANALYSIS

  • 1. Total Atrial Fibrillation Market-Dynamic SWOT Analysis
  • 2. PESTLE Analysis

11. COMPETITIVE LANDSCAPE

  • 1. AF Competitive Portfolio-Key and Niche Vendors
  • 2. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis
  • 3. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis (continued)
  • 4. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis (continued)
  • 5. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis (continued)
  • 6. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis (continued)
  • 7. Atrial Fibrillation Treatment Solution Providers-Vendor Analysis (continued)
  • 8. Clinical Trials
  • 9. Clinical Trials (continued)
  • 10. Industry Activity-by Key Vendors
  • 11. Industry Activity-by Key Vendors (continued)
  • 12. Atrial Fibrillation Market Scenario from 2020 to 2025
  • 13. Companies to Watch in 2020
  • 14. Technologies to Watch in 2020

12. THE LAST WORD

  • 1. Clinical Recommendations for Physicians
  • 2. Summary Recommendations
  • 3. Summary Recommendations (continued)
  • 4. Key Conclusions and Future Outlook
  • 5. The Last Word-3 Big Predictions
  • 6. Legal Disclaimer

13. APPENDIX

  • 1. Patient Classification
  • 2. Methodology

14. THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top